Description
Meloxicamisanon-steroidalanti-inflammatorydrug(NSAID)thatinhibitsCOX-2;itexhibitsanti-inflammatory,analgesic,antipyretic,neuroprotective,antioxidative,andhepatoprotectiveactivities.InanimalmodelsofParkinson’sdisease,meloxicaminhibitsMPTP-inducedmotordysfunctionandincreaseslevelsoftyrosinehydroxylase.InanimalmodelsofCCL(4)-inducedliverdamage,meloxicamincreaseslevelsofsuperoxidedismutase,catalase,andglutathione-S-transferaseanddecreaseslevelsofmalondialdehyde,prostaglandinE2(PGE2),andactivatedcaspase3.
References
TasakiY,YamamotoJ,OmuraT,etal.MeloxicamamelioratesmotordysfunctionanddopaminergicneurodegenerationbymaintainingAkt-signalinginamouseParkinson"sdiseasemodel.NeurosciLett.2012Jul11;521(1):15-9.PMID:22617635.
EdfawyM,HassanMH,MansourA,etal.Meloxicammodulatesoxidativestressstatus,inhibitsprostaglandinE2,andabrogatesapoptosisincarbontetrachloride-inducedrathepaticinjury.IntJToxicol.2012Jun;31(3):276-86.PMID:22556387.
NobleS,BalfourJA.Meloxicam.Drugs.1996Mar;51(3):424-32.PMID:8882380.
MalreddyPR,CoetzeeJF,KukanichB,GehringR.Pharmacokineticsandmilksecretionofgabapentinandmeloxicamco-admiNISTeredorallyinHolstein-Friesiancows.JVetPharmacolTher.2013Feb;36(1):14-20.PMID:22372845.
